ResearcherIntermountain Medical CenterNo recent work listed

Margaret Kelsey Baron

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-8115-7322; OpenAlex author ID A5016113504. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2021: 1 paper

Papers 1

Survival Outcomes Based on Sequence of Therapy Using FOLFIRINOX and Nab-Paclitaxel + Gemcitabine in Metastatic Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1097/mpa.0000000000001844 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Chris Nevala-Plagemann · 1 shared paper, 2021 · strength 0.16
- Paper Survival Outcomes Based on Sequence of Therapy Using FOLFIRINOX and Nab-Paclitaxel + Gemcitabine in Metastatic Pancreat… DOI 10.1097/mpa.0000000000001844 ↗
Ignacio Garrido‐Laguna · 1 shared paper, 2021 · strength 0.16
- Paper Survival Outcomes Based on Sequence of Therapy Using FOLFIRINOX and Nab-Paclitaxel + Gemcitabine in Metastatic Pancreat… DOI 10.1097/mpa.0000000000001844 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.